Can Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates Predict Bone Metastasis in Prostate Cancer Patients?


Creative Commons License

Ceylan Y., Tatlıdil S. , Şen S. , Sarsik B. , Özcan Z.

JOURNAL OF UROLOGICAL SURGERY, cilt.6, ss.105-110, 2019 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4274/jus.galenos.2018.2303
  • Dergi Adı: JOURNAL OF UROLOGICAL SURGERY
  • Sayfa Sayısı: ss.105-110

Özet

Objective: Bone metastasis is common in advanced prostate cancer (PCa). Recently, there has been a growing interest in the potential role of inflammatory markers, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and neutrophil-to-monocyte ratio (NMR), in predicting advanced disease in patients with solid tumors. In the current study, we aimed to assess the relationship of bone metastasis detected on bone scintigraphy (BS) with NLR, PLR, and NMR in patients with Pca.